Increasing count of amputees, patients with auditory loss, dental problems, and increasing availability of biocompatible materials

PORTLAND, OR, UNITED STATES, August 11, 2021 /EINPresswire.com/ -- 3D printing technology facilitates surgeons to improve the success rate of complicated procedures. Moreover, this technology has revolutionized preclinical drug testing by facilitating the testing on 3D-printed organs as an alternative to animal testing. The recent success in 3D printing of tablets has opened new avenues for use of 3D printing technology in the pharmaceutical industry.

3D Printing Healthcare Market generated $972.6 million in 2018 and is expected to generate $3.69 billion by 2026, registering a CAGR of 18.2% from 2019 to 2027. The report offers an extensive analysis of changing market trends, top winning strategies, drivers & opportunities, key segments, and competitive landscape.’

Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/834

Covid-19 Scenario:

• The demand for 3D printing healthcare has been increased in pharmaceutical and biotechnology companies for the diagnosis and research of vaccine on COVID 19 in the global lockdown.

• Research & development activities, on the other hand, in 3D printing healthcare has been increased during the global lockdown, owing to fulfill the demand in health care services.

High cost associated with 3D printers, copyright & patent infringement concerns, lack of quality & regulatory frameworks for 3D printers, reimbursement challenges, and concerns regarding mechanical properties & biocompatibility are the key factors responsible for hampering the market growth. Moreover, inadequate technical know-how in developing economies impedes the market growth.

Based on component, the system segment accounted for the highest market share in the global 3D printing healthcare market in 2018, contributing to more than half of the total share, and is estimated to maintain its leadership status during the forecast period. This is due to rapid adoption rate, advancements in technologies, and rise in biomedical applications. However, the materials segment is expected to register fastest CAGR of 20.0% from 2019 to 2027, owing to increase in requirement for biocompatible materials and system installation.

Based on application, the external wearable devices segment held nearly three-fifths of the total share in terms of revenue of the global 3D printing healthcare market in 2018, and will maintain its dominance by 2026. This is due to liberalization of regulations for 3D-printed medical devices, rise in patient-specific customizations, and huge patient pool suffering from cardiovascular & bone disorders, auditory loss, and dental problems. However, the tissue engineering segment is expected to register the highest CAGR of 22.2% from 2019 to 2027, owing to rise in R&D investments, rise in scope of biomedical applications, and technological advancements.

Interested to Procure The Data? Inquire here at https://www.alliedmarketresearch.com/purchase-enquiry/834

The key market players analyzed in the 3D printing healthcare market research report include 3D Systems Corporation, Exone, Formlabs, GE, Materialise NV, Oxferd Performance Materials, Inc., Organovo Holdings, Inc., Proto Labs, SLM Solutions Group AG, and Stratasys Ltd, Advanced Solutions Life Sciences, Aspect Biosystem, Cyfuse Biomedical K.K., Envisiontec, and Nano Dimension, and others

Trending Reports of Healthcare:-

Epilepsy Drug Market Global Opportunity Analysis and Industry Forecast, 2019–2026

CT Scanners Market Global Opportunity Analysis and Industry Forecast, 2019–2026

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.